Skip to main content
SpringerLink
Log in
Book cover

Inflammatory Bowel Disease: From Bench to Bedside pp 773–790Cite as

Special considerations in the diagnosis and management of inflammatory bowel disease in the pediatric age group

  • Chapter

  • 1270 Accesses

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Crohn’s disease in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival. Gastroenterology 1998; 114; 1161–8.

    Article  PubMed  Google Scholar 

  2. Logan RFA. Inflammatory bowel disease incidence: up, down or unchanged. Gut 1998; 42; 309–11.

    Article  PubMed  CAS  Google Scholar 

  3. Ogunbi SO, Ransom JA, Sullivan K, Schoen BT, Gold BD. Inflammatory bowel disease in African-American children living in Georgia. Pediatrics 1998; 138; 103–7.

    Google Scholar 

  4. Sawczenko A, Sandhu BK, Logan RF et al. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet 2001; 357; 1093–4

    Article  PubMed  CAS  Google Scholar 

  5. Seidman E. Inflammatory bowel diseases. In: Roy C, Silverman A, Alagille D, eds. Pediatric Clinical Gastroenterology, 4th edn. St Louis: CV Mosby, 1995; 417–93.

    Google Scholar 

  6. Marx G, Seidman EG. Inflammatory bowel diseases. In: C Lifschitz, ed. Pediatric Gastroenterology and Nutrition in Clinical Practice. New York: Marcel Decker, 2002; 651–82.

    Google Scholar 

  7. Seidman EG. Growth and nutritional problems in pediatric IBD. In: Bayless TM, Hanauer SB, eds. Advanced Therapy of Inflammatory Bowel Disease, 2nd edn. Hamilton, Ontario: BC Decker, 2002 (In press).

    Google Scholar 

  8. Pittock S, Drumm B, Fleming P et al. The oral cavity in Crohn’s disease. J Pediatr 2001; 138; 767–71.

    Article  PubMed  CAS  Google Scholar 

  9. Seidman EG. Role of endoscopy in pediatric inflammatory bowel disease. Gastrointest Endosc Clin N Am 2001; 11; 641–57.

    PubMed  CAS  Google Scholar 

  10. Murch SH, Walker-Smith J, Beattie RM. Indications for investigation of chronic gastrointestinal symptoms. Arch Dis Child 1995; 73; 354–5.

    PubMed  Google Scholar 

  11. Holmquist L, Ahren C, Feallstreom SP. Relationship between results of laboratory tests and inflammatory activity assessed by colonoscopy in children and adolescents with UC and Crohn’s colitis. J Pediatr Gastroenterol Nutr 1989; 9; 187–93.

    Article  PubMed  CAS  Google Scholar 

  12. Dubinsky MC, Seidman EG. Diagnostic markers of inflammatory bowel disease. Curr Opin Gastroenterol 2000; 16; 337–42.

    Article  PubMed  CAS  Google Scholar 

  13. Dubinsky MC, Ofman JJ, Urman M, Targan SR, Seidman EG. Clinical utility of serodiagnostic testing in suspected pediatric IBD. Am J Gastroenterol 2001; 96; 758–65.

    Article  PubMed  CAS  Google Scholar 

  14. Seidman E. Are serological tests for IBD useful to clinicians? Inflam Bowel Dis 1999; 5; 237.

    Article  Google Scholar 

  15. Ruemmele FM, Targan S, Levy G, Dubinsky M, Braun Seidman EG. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology 1998; 115: 822–9.

    Article  PubMed  CAS  Google Scholar 

  16. Hoffenberg E, Fidanza S, Sauaia A. Serologic testing for inflammatory bowel disease. J Pediatr 1999; 134; 447–52.

    Article  PubMed  CAS  Google Scholar 

  17. Seidman E. Gastrointestinal manifestations of primary immunodeficiency disorders. In: Walker WA, et al., eds. Pediatric Gastrointestinal Disease Pathophysiology, Diagnosis, Management, 3rd edn. Hamilton, Ontario: BC Decker, 2000; 525–47.

    Google Scholar 

  18. Scotiniotis I, Rubesin SE, Ginsberg GG. Imaging modalities in inflammatory bowel disease. Gastroenterol Clin N Am 1999; 28; 391–421.

    Article  CAS  Google Scholar 

  19. Ilnyckyj A, Greenberg H, Bernstein CN. Eschcrichia coli (157:H7 infection mimicking Crohn’s disease. Gastroenterology 1997; 113; 368.

    Google Scholar 

  20. Durno CA, Sherman P, Williams T, Shuckett B, Dupuis A, Griffiths AM. Magnetic resonance imaging to distinguish the type and severity ol’ pediatric inflammatory bowel diseases. J Pediatr Gastroenterol Nutr 2000; 30; 170–4.

    Article  PubMed  CAS  Google Scholar 

  21. Cucchiara S, Cclcntano L, de Magistris TM, Montisci A, Iula VD, Fecarotta S. Colonoscopy and technetium-99m white cell scan in children with suspected inflammatory bowel disease. J Pediatr 1999; 135; 727–32.

    Article  PubMed  CAS  Google Scholar 

  22. Charron M, Del Rosario F, Kocoshis S. Assessment of terminal ileal and colonic inflammation in Crohn’s disease with 99Tc-WBC. Ada Paediatr 1999; 88; 193–8.

    Article  CAS  Google Scholar 

  23. Spalinger JH, Patriquin H, Miron M-C et al. Doppler sonography in pediatric Crohn’s disease: Vessel density in the diseased bowel reflects disease activity. Radiology 2000; 217; 787–91.

    PubMed  CAS  Google Scholar 

  24. Deutsch DE, Olson AD. Colonoscopy or sigmoidoscopy as the initial evaluation of pediatric patients with colitis: a survey of physician behavior and cost analysis. J Pediatr Gastroenterol Nutr 1997; 25; 26–31.

    Article  PubMed  CAS  Google Scholar 

  25. Rutgeerts P, Vcrmcirc S. Serological diagnosis of inflammatory bowel disease. Lancet 2000; 356; 2117–18.

    Article  PubMed  CAS  Google Scholar 

  26. Marx G, Seidman, EG, Martin SR, Deslandres C. Outcome of patients with Crohn’s disease diagnosed before the age of two. J Pediatr 2002; 140; 470–3.

    Article  PubMed  Google Scholar 

  27. Russo PA, Brochu P, Seidman EG, Roy CC. Autoimmune enteropathy. Pediatr Dev Pathol 1999; 2; 65–71.

    Article  PubMed  CAS  Google Scholar 

  28. Miki K, Moore DJ, Butler RN, Southcott E, Couper RT, Davidson GP. The sugar permeability test reflects disease activity in children and adolescents with inflammatory bowel disease. J Pediatr 1998; 133; 750–4.

    Article  PubMed  CAS  Google Scholar 

  29. Seidman EG, Dubinsky M, Patriquin H, Marx G, Theoret Y. Recent developments in the diagnosis and management of paediatric IBD. In: CN Williams et al., eds. Trends in Inflammatory Bowel Disease Therapy 1999. Dordrecht, Netherlands: Kluwer Academic Publishers, 2000; 87–95.

    Google Scholar 

  30. Stein R, Hanauer S. Medical therapy for inflammatory bowel disease. Inflam Bowel Dis 1999; 28; 297–321.

    CAS  Google Scholar 

  31. Walker-Smith JA. Therapy of Crohn’s disease in childhood. Bailliere’s Clin Gastroenterol 1997; 11; 593–610.

    Article  CAS  Google Scholar 

  32. Del Rosario F, Orenstein SR, Neigut DA, Giarusso V, Wolfson N, Kocoshis SA. Retrospective analysis of alternate-day prednisone as maintenance therapy for Crohn’s disease. Clin Pediatr 1998; 37; 413–19.

    Google Scholar 

  33. Rutgeerts P, Lofberg R, Malchow H et al. A comparison of budesonide with prednisolone for active Crohn’s disease. N EnglJMed 1994; 331; 842.

    Article  CAS  Google Scholar 

  34. Steinhart AH, Feagan BG, Wong CJ et al. Combined budesonide and antibiotic therapy for active Crohn’s disease: a randomized controlled trial. Gastroenterology 2002; 123; 33–40.

    Article  PubMed  CAS  Google Scholar 

  35. Sandborn WJ. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine and methotrexate. Am J Gastroenterol 1996; 91; 423–33.

    PubMed  CAS  Google Scholar 

  36. Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn’s disease. A meta-analysis. Ann Intern Med 1995; 123; 132–42.

    PubMed  CAS  Google Scholar 

  37. Markowitz J, Grancher BS, Kohn N et al. A multicenter trial of 6-mercaptopurine and prednisone therapy in newly diagnosed children with Crohn’s disease. Gastroenterology 2000; 119: 895–902.

    Article  PubMed  CAS  Google Scholar 

  38. Seidman EG. 6-Mercaptopurine to maintain remission in Crohn’s disease: an old friend becomes a new hero. Gastroenterology 2000; 119: 1158–61.

    Article  PubMed  CAS  Google Scholar 

  39. Cuflari C, Theoret Y, Latour S, Seidman EG. 6-Mercaptopurine metabolism in Crohn’s disease: correlation with efficacy and toxicity. Gut 1996; 39; 401–6.

    Google Scholar 

  40. Dubinsky MC, Lamothe S, Yang HY et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 2000; 118; 705–13.

    Article  PubMed  CAS  Google Scholar 

  41. Black AJ, McLeod HL, Capell HA et al. Thiopurine methyltransferasc genotype predicts therapy-limiting severe toxicity from azathioprine. Ann Intern Med 1998; 129; 716–21

    PubMed  CAS  Google Scholar 

  42. Kirschner B. Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease. Gastroenterology 1998; 115; 813–21.

    Article  PubMed  CAS  Google Scholar 

  43. Sandborn WJ. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine and methotrexate. Am J Gastroenterol 1996; 91; 423–33.

    PubMed  CAS  Google Scholar 

  44. Kirschner BS. Methotrexate therapy for pediatric patients with inflammatory bowel disease. Inflam Bowel Dis 1998; 4: 121

    CAS  Google Scholar 

  45. Mack DR, Young R, Kaufman SS, Ramey L, Vanderhoof JA. Methotrexate in patients with Crohn’s disease after 6-mercaptopurine. Pediatrics 1998; 132; 830–5.

    Article  CAS  Google Scholar 

  46. Kugathasan S, Newman AJ, Dahms BB et al. Liver biopsy findings in patients with juvenile rheumatoid arthritis receiving long-term, weekly methotrexate therapy. J Pediatr 1996; 128; 149.

    Article  PubMed  CAS  Google Scholar 

  47. Cohen RD, Stein R, Hanauer SB. Intravenous cyclosporin in ulcerative colitis: a five year experience. Am J Gastroenterol 1999; 94: 1587–92.

    Article  PubMed  CAS  Google Scholar 

  48. Ramakrishna J, Langhans N, Calenda K et al. Combined use of cyclosporine and azathioprine or 6-mercaptopurine in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1996; 22; 296.

    Article  PubMed  CAS  Google Scholar 

  49. Hanauer SB, Smith MB. Rapid closure of Crohn’s fistulas with continuous intravenous cyclosporine A. Am J Gastroenterol 1993; 88: 646–9.

    PubMed  CAS  Google Scholar 

  50. Mahdi G, Israel DM, Hassal E. Cyclosporine and 6-mercaptopurine for active, refractory Crohn’s colitis in children. Am J Gastroenterol 1996; 91; 1355–9.

    PubMed  CAS  Google Scholar 

  51. Bousvaros A, Kirschner BS, Werlin SL et al. Oral tacrolimus treatment of severe colitis in children. J Pediatr 2000; 137; 794–9.

    Article  PubMed  CAS  Google Scholar 

  52. Targan SR, Hanauer SB, van Deventer SJ et al. A short term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn’s disease. N Engl J Med 1997; 337: 1029–35.

    Article  PubMed  CAS  Google Scholar 

  53. Present DH, Rutgeerts P, Targan S et al. Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med 1999; 340; 1398–405.

    Article  PubMed  CAS  Google Scholar 

  54. Sandborn W, Hanauer S. Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results and safety. Inflam Bowel Dis 1999; 5; 119–33.

    Article  CAS  Google Scholar 

  55. Hyams JS, Markowitz J, Wyllie R. Use of infliximab in the treatment of Crohn’s disease in children and adolescents. J Pediatr 2000; 137; 192–6.

    Article  PubMed  CAS  Google Scholar 

  56. Puchner TC, Kugathasan S, Kelley SJ, Binion DG. Successful desensitization and therapeutic use of infliximab in adult and pediatric Crohn’s disease patients with prior anaphylactic reactions. Inflam Bowel Dis 2001; 7; 34–7.

    Article  CAS  Google Scholar 

  57. Van Deventer SJ, Elson CO, Fedorak RN. Multiple doses of intravenous IL-10 in steroid-refractory Crohn’s disease. Gastroenterology 1997; 113; 383–9.

    Article  PubMed  Google Scholar 

  58. Madsen SM, Schlichting P, Davidsen B et al. An openlabeled, randomized study comparing systemic interferon-a-2A and prednisolone enemas in the treatment of left-sided ulcerative colitis. Am J Gastroenterol 2001; 96; 1807–15.

    PubMed  CAS  Google Scholar 

  59. Hadziselimovic F, Emmons L, Schaub U. Interferon-alpha-2a (Roferon) treatment of inflammatory bowel disease in children and adolescents. In: Hadziselimovic F, Herzog D, eds. Inflammatory Bowel Disease and Morbus Hirschsprung. Falk Symposium on Paediatric and Surgical Gastroenterology, Basel, Switzerland. Dordrecht, Kluwer Academic Publishers, 1992; 109–23.

    Google Scholar 

  60. Palder SB, Shandling B, Bilik R et al. Perianal complications of pediatric perianal Crohn’s disease. J Pediatr Surg 1991; 26; 513

    Article  PubMed  CAS  Google Scholar 

  61. Duffy LF, Daum F, Fisher SE et al. Peripheral neuropathy in Crohn’s disease patients treated with metronidazole. Gastroenterology 1985; 88; 681

    PubMed  CAS  Google Scholar 

  62. Prantera C, Zannoni F, Scribano ML et al. An antibiotic regimen for the treatment of active Crohn’s disease: a randomized, controlled trial of metronidazole plus ciprofloxacin. Am J Gastroenterol 1996; 91; 328

    PubMed  CAS  Google Scholar 

  63. Colombel JF, Lemann M, Cassagnou M et al. A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn’s disease. Am J Gasroenterol 1999; 94: 674

    Article  CAS  Google Scholar 

  64. Kubin R. Safety and efficacy of ciprofloxacin in pediatric patients — review. Infection 1993; 21; 413.

    Article  PubMed  CAS  Google Scholar 

  65. Seidman EG. Nutritional management of inflammatory bowel disease. Gastroenterol Clin N Am 1989; 18; 129–55.

    CAS  Google Scholar 

  66. Seidman EG, LeLeiko N, Ament M et al. Nutritional issues in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1991; 12; 424–38.

    Article  PubMed  CAS  Google Scholar 

  67. Atlan Ph, Seidman E. Nutritional considerations in pediatric patients. Can J Gastroenterol 1990; 4; 41–47.

    Google Scholar 

  68. Ruemmele F, Roy CC, Levy E, Seidman EG. The role of nutrition in treating pediatric Crohn’s disease in the new millennium. J Pediatrics 2000; 136; 285–91.

    Article  CAS  Google Scholar 

  69. Seidman EG. Nutritional therapy for Crohn’s disease: lessons from the Ste.-Justine Hospital experience. Inflam Bowel Dis 1997; 3; 49–53.

    Article  Google Scholar 

  70. Griffith AM, Ohlsson A, Sherman PM, Sutherland LR. Meta-analysis of enteral nutrition as a primary treatment of active Crohn’s disease. Gastroenterology 1995; 108; 1056–67.

    Article  Google Scholar 

  71. Belli D, Seidman EG, Bouthillier L et al. Chronic intermittent elemental diet improves growth failure in children with Crohn’s disease. Gastroenterology 1988; 94; 603–10.

    PubMed  CAS  Google Scholar 

  72. Seidman EG, Jones A, Issenman R, Griffith A. Relapse prevention/growth enhancement in pediatric Crohn’s disease: multicenter randomized controlled trial of intermittent enteral nutrition versus alternate day prednisone. J Pediatr Gastroenterol Nutr 1996; 23; 344.

    Google Scholar 

  73. Teahon K, Smethurst P, Person M et al. The effect of elemental diet on permeability and inflammation in Crohn’s disease. Gastroenterology 1991; 101; 84–9.

    PubMed  CAS  Google Scholar 

  74. Belluzzi A, Brignola C, Campieri M et al. Effect of an enteric-coated fish-oil preparation on relapses in Crohn’s disease. N Engl J Med 1996; 334; 1557.

    Article  PubMed  CAS  Google Scholar 

  75. Salvatore S, Heuschkel R, Tomlin S et al. A pilot study of N-acetyl glucosamine, a nutritional substrate for glycosaminoglycan synthesis, in paediatric chronic inflammatory bowel disease. Aliment Pharmacol Ther 2000; 14; 1567–79.

    Article  PubMed  CAS  Google Scholar 

  76. Markowitz J, Grancher K, Rosa J et al. Growth failure in pediatric inflammatory bowel disease. J Pediatr Gastroenterology Nutr 1994; 16; 373–80.

    Article  Google Scholar 

  77. Sentongo TA, Stettler N, Christian A, Han PD, Stallings VA, Baldassano RN. Growth after intestinal resection for Crohn’s disease in children, adolescents, and young adults. Inflam Bowel Dis 2000; 6; 265–9.

    Article  CAS  Google Scholar 

  78. Castile RG, Telander RC, Cooney DR et al. Crohn’s disease in children: assessment of the progression of disease, growth and prognosis. J Pediatr Surg 1980; 15; 462–9.

    PubMed  CAS  Google Scholar 

  79. D’Agata I, Seidman E. Dietary manipulation — parenteral. In: Allan RD et al., eds. Inflammatory Bowel Diseases, 3rd edn. New York: Churchill Livingstone,1997; 541–5.

    Google Scholar 

  80. Herzog D, Bishop N, Glorieux F, Seidman EG. Interpretation of bone mineral density values in pediatric Crohn’s disease. Inflam Bowel Dis 1998; 4; 261–7.

    Article  CAS  Google Scholar 

  81. Gokhale R, Favus MJ, Karrison T, Sutton M, Rich B, Kirschner BS. Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology 1998; 114: 902–11.

    Article  PubMed  CAS  Google Scholar 

  82. Moody G, Eaden JA, Mayberry JF. Social implications of childhood Crohn’s disease. J Pediatr Gastroenterol Nutr 1999; 28; S43–5.

    Article  PubMed  CAS  Google Scholar 

  83. Lavigne JV, Faier-Routman J. Correlates of psychological adjustment to pediatric physical disorders: a meta-analytic review and comparison with existing models. J Dev Behav Pediatr 1993; 14; 117–23.

    Article  PubMed  CAS  Google Scholar 

  84. Rickards H, Prendergast M, Booth IW. Psychiatric presentation of Crohn’s disease. Diagnostic delay and increased morbidity. Br J Psychiatry 1994; 164; 256–61.

    PubMed  CAS  Google Scholar 

  85. Thienemann M, Steiner H. Psychometric measures in clarifying diagnosis in malnourished adolescents. Acta Paedopsychiatr 1992; 55; 207–11.

    PubMed  CAS  Google Scholar 

  86. Burke P, Meyer V, Kocoshis S et al. Depression and anxiety in pediatric inflammatory bowel disease and cystic fibrosis. J Am Acad Child Adolesc Psychiatry 1989; 28; 948–51.

    Article  PubMed  CAS  Google Scholar 

  87. Engstrom I. Mental health and psychological functioning in children and adolescents with inflammatory bowel disease: a comparison with children having other chronic illnesses and with healthy children. J Child Psychol Psychiatry 1992; 33; 563–82.

    Article  PubMed  CAS  Google Scholar 

  88. Steinhausen HC, Kies H. Comparative studies of ulcerative colitis and Crohn’s disease in children and adolescents. J Child Psychol Psychiatry 1982; 23; 33–42.

    Article  PubMed  CAS  Google Scholar 

  89. Szajnberg N, Krall V, Davis P, Treem W, Hyams J. Psychopathology and relationship measures in children with in flammatory bowel disease and their parents. Child Psychiatry Hum Dev 1993; 2; 215–32.

    Article  Google Scholar 

  90. Engstrom I. Family interaction and locus of control in children and adolescents with inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry 1991; 30; 913–20.

    Article  PubMed  CAS  Google Scholar 

  91. Akobeng AK, Miller V, Firth D, Suresh-Babu MV, Mir P, Thomas AG. Quality of life of parents and siblings of children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1999; 28; S40–2.

    Article  PubMed  CAS  Google Scholar 

  92. Mullen RS, Romans-Clarkson SE. Behavioural sensitisation and steroid-induced psychosis. Br J Psychiatry 1993; 162; 549–51.

    Article  PubMed  CAS  Google Scholar 

  93. Griffith AM, Wesson DE, Shanding B et al. Factors influencing postoperative recurrence of Crohn’s disease in childhood. Gut 1991; 32: 491–5.

    Google Scholar 

  94. Davies G, Evans CM, Shand WS, Walker-Smith JA. Surgery for Crohn’s disease in childhood: influence of site of disease and operative procedure on outcome. Br J Surg 1990; 77: 891–4.

    Article  PubMed  CAS  Google Scholar 

  95. Telander RL. Surgical management of inflammatory bowel disease in children: In: Telander R, ed. Problems in General Surgery: Surgical Treatment of Inflammatory Bowel Disease. Philadelphia, JB Lippincott, 1993.

    Google Scholar 

  96. Martin LW, LeCoultre C, Schubert WK. Total colectomy and mucosal proctectomy with preservation of continence. Ann Surg 1977; 186:477–80.

    Article  PubMed  CAS  Google Scholar 

  97. Tiszlavicz L, Kapin M, Varkonyi A, Lorincz A, Bartyik K, Varkonyi T. Adenocarcinoma of the colon developing on the basis of Crohn’s disease in childhood. Eur J Pediatr 2001; 160: 168–72

    Article  PubMed  CAS  Google Scholar 

  98. Gillen CD, Walmsley RS, Prior P et al. Ulcerative colitis and Crohn’s disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 1994; 35: 1590–2.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Hepatology and Nutrition, Sainte Justine Hospital, Canada

    Ernest G. Seidman (Professor and Chief)

  2. Department of Pediatrics, University of Montreal, Quebec, Canada

    Ernest G. Seidman (Professor and Chief) & Arlene Caplan (Clinical Psychologist and Associated Professor)

  3. Division of Gastroenterolog, Hepatology, Hopital Sainte Justine, Canada

    Arlene Caplan (Clinical Psychologist and Associated Professor)

Authors
  1. Ernest G. Seidman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arlene Caplan
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cedars-Sinai IBD Center, Los Angeles, CA, USA

    Stephan R. Targan  & Loren C. Karp  & 

  2. Cork University Hospital, Cork, Ireland

    Fergus Shanahan

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Kluwer Academic Publishers

About this chapter

Cite this chapter

Seidman, E.G., Caplan, A. (2003). Special considerations in the diagnosis and management of inflammatory bowel disease in the pediatric age group. In: Targan, S.R., Shanahan, F., Karp, L.C. (eds) Inflammatory Bowel Disease: From Bench to Bedside. Springer, Boston, MA. https://doi.org/10.1007/0-387-25808-6_42

Download citation

  • DOI: https://doi.org/10.1007/0-387-25808-6_42

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-25807-2

  • Online ISBN: 978-0-387-25808-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation